119 related articles for article (PubMed ID: 1394706)
1. Enzymatic synthesis of glucoside derivatives of validamine and valienamine.
Furumoto T; Kameda Y; Matsui K
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1871-5. PubMed ID: 1394706
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of validamine, valienamine and valiolamine on activities of carbohydrases in rat small intestinal brush border membranes.
Takeuchi M; Takai N; Asano N; Kameda Y; Matsui K
Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1970-2. PubMed ID: 2268898
[TBL] [Abstract][Full Text] [Related]
3. Novel synthesis of natural pseudo-aminosugars, (+)-valienamine and (+)-validamine.
Tatsuta K; Mukai H; Takahashi M
J Antibiot (Tokyo); 2000 Apr; 53(4):430-5. PubMed ID: 10866227
[No Abstract] [Full Text] [Related]
4. Stereoselective synthesis of a 4-⍺-glucoside of valienamine and its X-ray structure in complex with Streptomyces coelicolor GlgE1-V279S.
Si A; Jayasinghe TD; Thanvi R; Kapil S; Ronning DR; Sucheck SJ
Sci Rep; 2021 Jun; 11(1):13413. PubMed ID: 34183716
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of pseudo-aminosugars on oligosaccharide glucosidases I and II and on lysosomal alpha-glucosidase from rat liver.
Takeuchi M; Kamata K; Yoshida M; Kameda Y; Matsui K
J Biochem; 1990 Jul; 108(1):42-6. PubMed ID: 2229010
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of valienamine and validamine by thin-layer chromatography.
Xue YP; Zheng YG; Chen XL; Shen YC
J Chromatogr Sci; 2007 Feb; 45(2):87-90. PubMed ID: 17425137
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of an alpha-fucosidase inhibitor, 5a-carba-beta-L-fucopyranosylamine, and fucose-type alpha- and beta-DL-valienamine unsaturated derivatives.
Ogawa S; Watanabe M; Maruyama A; Hisamatsu S
Bioorg Med Chem Lett; 2002 Mar; 12(5):749-52. PubMed ID: 11858994
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of 5a-carbaglycopyranosylamime glycosidase inhibitors.
Ogawa S; Kanto M
Curr Top Med Chem; 2009; 9(1):58-75. PubMed ID: 19199996
[TBL] [Abstract][Full Text] [Related]
9. Valiolamine, a new alpha-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus.
Kameda Y; Asano N; Yoshikawa M; Takeuchi M; Yamaguchi T; Matsui K; Horii S; Fukase H
J Antibiot (Tokyo); 1984 Nov; 37(11):1301-7. PubMed ID: 6392268
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered production of 1,1'-bis-valienamine and validienamycin in Streptomyces hygroscopicus and their conversion to valienamine.
Xu H; Yang J; Bai L; Deng Z; Mahmud T
Appl Microbiol Biotechnol; 2009 Jan; 81(5):895-902. PubMed ID: 18820907
[TBL] [Abstract][Full Text] [Related]
11. Enzymic synthesis of alpha- and beta-D-glucosides of 1-deoxynojirimycin and their glycosidase inhibitory activities.
Asano N; Oseki K; Kaneko E; Matsui K
Carbohydr Res; 1994 May; 258():255-66. PubMed ID: 8039179
[TBL] [Abstract][Full Text] [Related]
12. Enzymic synthesis of valienamine glucosides and their antibiotic activity.
Furumoto T; Yoshioka T; Kamata K; Kameda Y; Matsui K
J Antibiot (Tokyo); 1991 Mar; 44(3):371-3. PubMed ID: 2026563
[No Abstract] [Full Text] [Related]
13. Inhibition of porcine small intestinal sucrase by valienamine.
Zheng YG; Shentu XP; Shen YC
J Enzyme Inhib Med Chem; 2005 Feb; 20(1):49-53. PubMed ID: 15895684
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents.
Horii S; Fukase H; Matsuo T; Kameda Y; Asano N; Matsui K
J Med Chem; 1986 Jun; 29(6):1038-46. PubMed ID: 3519969
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and α-Glucosidase II inhibitory activity of valienamine pseudodisaccharides relevant to N-glycan biosynthesis.
Cumpstey I; Ramstadius C; Eszter Borbas K; Alonzi DS; Butters TD
Bioorg Med Chem Lett; 2011 Sep; 21(18):5219-23. PubMed ID: 21840710
[TBL] [Abstract][Full Text] [Related]
16. A new synthesis of valienamine.
Kok SH; Lee CC; Shing TK
J Org Chem; 2001 Oct; 66(21):7184-90. PubMed ID: 11597249
[No Abstract] [Full Text] [Related]
17. Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.
Łysek R; Schütz C; Favre S; O'Sullivan AC; Pillonel C; Krülle T; Jung PM; Clotet-Codina I; Esté JA; Vogel P
Bioorg Med Chem; 2006 Sep; 14(18):6255-82. PubMed ID: 16797996
[TBL] [Abstract][Full Text] [Related]
18. Transformation of quercitols into 4-methylenecyclohex-5-ene-1,2,3-triol derivatives, precursors for the chemical chaperones N-octyl-4-epi-β-valienamine (NOEV) and N-octyl-β-valienamine (NOV).
Kuno S; Takahashi A; Ogawa S
Bioorg Med Chem Lett; 2011 Dec; 21(23):7189-92. PubMed ID: 22001090
[TBL] [Abstract][Full Text] [Related]
19. Valienamine as an alpha-glucosidase inhibitor.
Kameda Y; Asano N; Yoshikawa M; Matsui K
J Antibiot (Tokyo); 1980 Dec; 33(12):1575-6. PubMed ID: 6788743
[No Abstract] [Full Text] [Related]
20. Properties and production of valienamine and its related analogues.
Chen X; Fan Y; Zheng Y; Shen Y
Chem Rev; 2003 May; 103(5):1955-77. PubMed ID: 12744697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
